PharmaCyte is preparing for a clinical trial using the Cell-in-a-Box® technology. The trial will be led by renowned cancer specialist Dr. Manuel Hidalgo of Beth Israel Deaconess Medical Center in Boston.
The trial will be a two-armed, with approximately 250-patients enrolled and with approximately 125 patients in each arm. It will be conducted in the U.S. with possible study sites in Europe. Currently, we are working on gathering all the items the FDA requires from us before submitting the IND application. Once the IND and clinical trial are approved, we will begin the process of screening patients to participate.
(See pg. 27 of MicroCap Review for our recent feature) http://www.microcapreview.com/issues/?utm_source=Facebook&utm_campaign=MicroCap